Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

V. S. Sabine; C. Crozier; C. L. Brookes; C. Drake; T. Piper; C. J. H. Van De Velde; A. Hasenburg; D. G. Kieback; C. Markopoulos; L. Dirix; C. Seynaeve; D. W. Rea; John M. S. Bartlett

doi:10.1200/JCO.2013.53.8272

Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

V. S. Sabine, C. Crozier, C. L. Brookes, C. Drake, T. Piper, C. J. H. Van De Velde, A. Hasenburg, D. G. Kieback, C. Markopoulos, L. Dirix, C. Seynaeve, D. W. Rea, John M. S. Bartlett

Cancer Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

79 Citations (Scopus)

Original language	English
Pages (from-to)	2951-2958
Journal	Journal of Clinical Oncology
Volume	32
Issue number	27
DOIs	https://doi.org/10.1200/JCO.2013.53.8272
Publication status	Published - 20 Sept 2014

Access to Document

10.1200/JCO.2013.53.8272

http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.53.8272

Cite this

Sabine, V. S., Crozier, C., Brookes, C. L., Drake, C., Piper, T., Van De Velde, C. J. H., Hasenburg, A., Kieback, D. G., Markopoulos, C., Dirix, L., Seynaeve, C., Rea, D. W., & Bartlett, J. M. S. (2014). Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study. Journal of Clinical Oncology, 32(27), 2951-2958. https://doi.org/10.1200/JCO.2013.53.8272

@article{f9999653156541d4885b7cefcf9aa481,

title = "Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study",

author = "Sabine, {V. S.} and C. Crozier and Brookes, {C. L.} and C. Drake and T. Piper and {Van De Velde}, {C. J. H.} and A. Hasenburg and Kieback, {D. G.} and C. Markopoulos and L. Dirix and C. Seynaeve and Rea, {D. W.} and Bartlett, {John M. S.}",

year = "2014",

month = sep,

day = "20",

doi = "10.1200/JCO.2013.53.8272",

language = "English",

volume = "32",

pages = "2951--2958",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "27",

}

Sabine, VS, Crozier, C, Brookes, CL, Drake, C, Piper, T, Van De Velde, CJH, Hasenburg, A, Kieback, DG, Markopoulos, C, Dirix, L, Seynaeve, C, Rea, DW & Bartlett, JMS 2014, 'Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study', Journal of Clinical Oncology, vol. 32, no. 27, pp. 2951-2958. https://doi.org/10.1200/JCO.2013.53.8272

TY - JOUR

T1 - Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

AU - Sabine, V. S.

AU - Crozier, C.

AU - Brookes, C. L.

AU - Drake, C.

AU - Piper, T.

AU - Van De Velde, C. J. H.

AU - Hasenburg, A.

AU - Kieback, D. G.

AU - Markopoulos, C.

AU - Dirix, L.

AU - Seynaeve, C.

AU - Rea, D. W.

AU - Bartlett, John M. S.

PY - 2014/9/20

Y1 - 2014/9/20

U2 - 10.1200/JCO.2013.53.8272

DO - 10.1200/JCO.2013.53.8272

M3 - Article

SN - 0732-183X

VL - 32

SP - 2951

EP - 2958

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 27

ER -